// App-Quantinova.ai

2139 : Predictors of Radiologic Disease Progression during the Rheumatoid Arthritis Comparison of Active Therapies Trial

Researchers

Presenter

  • Alan Erickson

Principal Investigators

  • Denis Rybin

  • Mary Brophy

  • Robert Lew

  • Ted R. Mikuls

  • Timothy Moore

  • Keri Hannagan

  • Edward Keystone

  • James - Dell

Medical Centers

  • University of Nebraska Medical Center, Omaha, NE

  • Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

  • VA Boston Healthcare System, Boston, MA

  • MAVERIC CSPCC MAV, VA Boston Healthcare System, Boston, MA

  • University of Toronto - Mount Sinai Hospital, Toronto, ON, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved